VANECK ETF TR (BBH) - 5i Research

VANECK ETF TR (BBH $199.35)
- $199.35 P/E (TTM): 20.86X Cap: $396M
- View BBH Profile
- View Questions on BBH

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

iShares Biotechnology ETF (IBB $174.98)
- $174.98 P/E (TTM): 20.63X Cap: $8.66B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $41.01)
- $41.01 Cap: $16.02B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $199.35)
- $199.35 P/E (TTM): 20.86X Cap: $396M
- View BBH Profile
- View Questions on BBH

Q: Currently not invested in this sector. Considering starting a position in this company. Appreciate your insights.
Thank you

Read Answer Asked by Larry on September 07, 2023

iShares Biotechnology ETF (IBB $174.98)
- $174.98 P/E (TTM): 20.63X Cap: $8.66B
- View IBB Profile
- View Questions on IBB
CRISPR Therapeutics AG (CRSP $48.74)
- $48.74 Cap: $4.64B
- View CRSP Profile
- View Questions on CRSP
VANECK ETF TR (BBH $199.35)
- $199.35 P/E (TTM): 20.86X Cap: $396M
- View BBH Profile
- View Questions on BBH

Q: I am down by 55% on this company, although it is a small position (.8%) & I consider it speculative. Your comments will help me decide to wait, sell, or buy more. Thanks

Read Answer Asked by Louisa on March 30, 2023

Regeneron Pharmaceuticals Inc. (REGN $785.51)
- $785.51 P/E (TTM): 18.33X Cap: $83.04B
- View REGN Profile
- View Questions on REGN
Johnson & Johnson (JNJ $239.99)
- $239.99 P/E (TTM): 22.95X Cap: $578.20B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $1,058.18)
- $1,058.18 P/E (TTM): 49.94X Cap: $1T
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $121.93)
- $121.93 P/E (TTM): 15.83X Cap: $302.63B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $27.22)
- $27.22 P/E (TTM): 15.4X Cap: $154.76B
- View PFE Profile
- View Questions on PFE
Thermo Fisher Scientific Inc (TMO $542.83)
- $542.83 P/E (TTM): 31.33X Cap: $203.94B
- View TMO Profile
- View Questions on TMO
Novo Nordisk A/S (NVO $47.64)
- $47.64 P/E (TTM): 12.31X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $174.98)
- $174.98 P/E (TTM): 20.63X Cap: $8.66B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $41.01)
- $41.01 Cap: $16.02B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $199.35)
- $199.35 P/E (TTM): 20.86X Cap: $396M
- View BBH Profile
- View Questions on BBH
iShares U.S. Pharmaceuticals ETF (IHE $90.36)
- $90.36 P/E (TTM): 21.49X Cap: $1.01B
- View IHE Profile
- View Questions on IHE

Q: I'm looking for names in the large cap pharma and biotech sectors. Can you suggest two stocks for each sector that look attractive to you right now for a 5+ year horizon? Thanks.

Read Answer Asked by Stefan on March 10, 2023